Stemchymal® for Polyglutamine Spinocerebellar Ataxia

Clinical trial NCT06397274 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06397274
Sponsor: Steminent US, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Spinocerebellar Ataxias

Start date: 2025-06-01
Primary completion: 2028-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.